Position in IBRX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$208,369
+$25,823 QoQ
Shares Held
23,800
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#219
of 401 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DILLON & ASSOCIATES INC holds $2,756,153 across 2 Biotechnology names. IBRX ranks #2 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,086 | $2,547,784 | |
| 2 | IBRX |
ImmunityBio, Inc.
This page
|
23,800 | $208,369 |
All Filings in IBRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $208,369 | 23,800 | Shares | Other | 2026-08-05 | |
| 2026-03-31 | $182,546 | 23,800 | Shares | Other | 2026-05-07 | |
| 2025-12-31 | $51,084 | 25,800 | Shares | Other | 2026-02-09 | |
| 2025-09-30 | $52 | 25,800 | Shares | Other | 2025-10-28 | |
| 2025-06-30 | $77 | 25,800 | Shares | Other | 2025-08-05 | |
| No filing history on record for this holder in this stock. | ||||||